Evidence map›Paper›PMID 34066698›Full record

ArticleJournal of clinical medicine2021

Galectin-3-A New Player of Kidney Damage or an Innocent Bystander in Children with a Single Kidney?

Eryk Latoch, Katarzyna Konończuk, Anna Jander, Elżbieta Trembecka-Dubel, Anna Wasilewska, Katarzyna Taranta-Janusz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Eryk LatochDepartment of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Białystok, Poland.ORCID 0000-0002-7667-7953
Katarzyna KonończukDepartment of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-274 Białystok, Poland.ORCID 0000-0003-0540-8040
Anna JanderDepartment of Pediatrics, Immunology and Nephrology, Polish Mother's Memorial Hospital Research Institute, 93-338 Łódź, Poland.
Elżbieta Trembecka-DubelDepartment of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland.
Anna WasilewskaDepartment of Pediatrics and Nephrology, Medical University of Bialystok, 15-274 Białystok, Poland.
Katarzyna Taranta-JanuszDepartment of Pediatrics and Nephrology, Medical University of Bialystok, 15-274 Białystok, Poland.ORCID 0000-0002-8762-8866
Medical University of Białystok · PLMedical University of Silesia · PLPolish Mother’s Memorial Hospital Research Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the galectin-3 (Gal-3) level in children with a congenital solitary functioning kidney (cSFK) and determine its association with common renal function parameters. The study consisted of 68 children (49 males) with cSFK. We demonstrated that children with cSFK had a lower level of galectin-3 than that of healthy subjects (

Indexed as

childrenchronic kidney diseasecystatin Cgalectin-3solitary functioning kidney

Identifiers

PMID34066698
PMCPMC8125852
OpenAlexW3161855771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.